Alphatec Stock Price, News & Analysis (NASDAQ:ATEC)

$3.25 +0.03 (+0.93 %)
(As of 02/16/2018 04:00 PM ET)
Previous Close$3.25
Today's Range$3.08 - $3.44
52-Week Range$1.58 - $5.80
Volume129,785 shs
Average Volume108,815 shs
Market Capitalization$54.86 million
P/E Ratio-1.48
Dividend YieldN/A
Beta1.49

About Alphatec (NASDAQ:ATEC)

Alphatec logoAlphatec Holdings, Inc. is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc. and its subsidiaries, designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures. Its products include Cervical and Cervico-Thoracic Products, which include Trestle Luxe Anterior Cervical Plate System and Pegasus Anchored Cervical Interbody; Thoracolumbar Fixation Products, which include Arsenal Degenerative System and OsseoScrew Spinal Fixation System; Spinal Spacers, which include Battalion Universal Spacer System and Alphatec Solus Locking ALIF Spinal Spacer; minimally invasive surgery Products, which include Illico Minimally Invasive Surgery System and BridgePoint Spinous Process Fixation System, and Biologics, which include Neocore Osteoconductive Matrix.

Receive ATEC News and Ratings via Email

Sign-up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Diagnostic & Testing Equipment
Sub-IndustryHealth Care Equipment
SectorHealthcare
SymbolNASDAQ:ATEC
CUSIP02081G10
Phone+1-760-4319286

Debt

Debt-to-Equity Ratio-1.11%
Current Ratio2.11%
Quick Ratio1.08%

Price-To-Earnings

Trailing P/E Ratio-1.47727272727273
Forward P/E Ratio-3.13
P/E GrowthN/A

Sales & Book Value

Annual Sales$120.25 million
Price / Sales0.45
Cash FlowN/A
Price / CashN/A
Book Value($4.66) per share
Price / Book-0.70

Profitability

Trailing EPS($2.20)
Net Income$-29,920,000.00
Net Margins-15.69%
Return on EquityN/A
Return on Assets-25.26%

Miscellaneous

Employees162
Outstanding Shares16,720,000

Alphatec (NASDAQ:ATEC) Frequently Asked Questions

What is Alphatec's stock symbol?

Alphatec trades on the NASDAQ under the ticker symbol "ATEC."

How were Alphatec's earnings last quarter?

Alphatec Holdings, Inc. (NASDAQ:ATEC) released its earnings results on Tuesday, March, 15th. The medical technology company reported ($0.03) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.05) by $0.02. The medical technology company earned $47 million during the quarter, compared to analyst estimates of $50.01 million. View Alphatec's Earnings History.

Where is Alphatec's stock going? Where will Alphatec's stock price be in 2018?

2 brokerages have issued 12 month price targets for Alphatec's stock. Their predictions range from $4.00 to $7.00. On average, they expect Alphatec's stock price to reach $5.50 in the next year. View Analyst Ratings for Alphatec.

Who are some of Alphatec's key competitors?

Who are Alphatec's key executives?

Alphatec's management team includes the folowing people:

  • Patrick S. Miles, Chairman of the Board (Age 51)
  • Terry M. Rich, Chief Executive Officer, Director (Age 48)
  • Jeffrey G. Black, Chief Financial Officer, Executive Vice President (Age 48)
  • Jonathan Allen, Executive Vice President - Commercial Operations
  • Craig E. Hunsaker, Executive Vice President - People and Culture (Age 50)
  • Kristin Machacek Leary, Senior Vice President - Global Human Resources (Age 47)
  • Dennis T. Nelson, Vice President - Finance, Corporate Controller (Age 43)
  • Michael Dendinger, Vice President - Operations
  • Amy Ables Ph.D., Vice President - Corporate Education & Performance
  • Lance Denardin, Vice President - West

Who owns Alphatec stock?

Alphatec's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Armistice Capital LLC (4.66%), Renaissance Technologies LLC (2.15%), Fondren Management LP (1.50%), HPM Partners LLC (1.16%), Broadfin Capital LLC (0.87%) and HBK Sorce Advisory LLC (0.40%). Company insiders that own Alphatec stock include Brian Snider, Jeffrey G Black, John Foster, Leslie H Cross and Terry Rich. View Institutional Ownership Trends for Alphatec.

Who sold Alphatec stock? Who is selling Alphatec stock?

Alphatec's stock was sold by a variety of institutional investors in the last quarter, including Fondren Management LP. View Insider Buying and Selling for Alphatec.

Who bought Alphatec stock? Who is buying Alphatec stock?

Alphatec's stock was acquired by a variety of institutional investors in the last quarter, including HPM Partners LLC, Broadfin Capital LLC, Armistice Capital LLC, HBK Sorce Advisory LLC and Renaissance Technologies LLC. Company insiders that have bought Alphatec stock in the last two years include Brian Snider, Jeffrey G Black, Leslie H Cross and Terry Rich. View Insider Buying and Selling for Alphatec.

How do I buy Alphatec stock?

Shares of Alphatec can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Alphatec's stock price today?

One share of Alphatec stock can currently be purchased for approximately $3.25.

How big of a company is Alphatec?

Alphatec has a market capitalization of $54.86 million and generates $120.25 million in revenue each year. The medical technology company earns $-29,920,000.00 in net income (profit) each year or ($2.20) on an earnings per share basis. Alphatec employs 162 workers across the globe.

How can I contact Alphatec?

Alphatec's mailing address is 5818 El Camino Real, CARLSBAD, CA 92008, United States. The medical technology company can be reached via phone at +1-760-4319286 or via email at [email protected]


MarketBeat Community Rating for Alphatec (ATEC)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  108 (Vote Outperform)
Underperform Votes:  109 (Vote Underperform)
Total Votes:  217
MarketBeat's community ratings are surveys of what our community members think about Alphatec and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Alphatec (NASDAQ:ATEC) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $5.50$5.50$5.50$4.00
Price Target Upside: 83.95% upside83.95% upside52.35% upside138.11% upside

Alphatec (NASDAQ:ATEC) Consensus Price Target History

Price Target History for Alphatec (NASDAQ:ATEC)

Alphatec (NASDAQ:ATEC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/22/2017HC WainwrightReiterated RatingBuy$4.00N/AView Rating Details
10/16/2017Lake Street CapitalInitiated CoverageBuy -> Buy$7.00N/AView Rating Details
3/14/2016Northland SecuritiesDowngradeOutperform -> UnderperformN/AView Rating Details
(Data available from 2/17/2016 forward)

Earnings

Alphatec (NASDAQ:ATEC) Earnings History and Estimates Chart

Earnings by Quarter for Alphatec (NASDAQ:ATEC)

Alphatec (NASDAQ ATEC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2017Q3 2017($0.15)($0.22)$23.10 millionViewN/AView Earnings Details
8/10/2017Q2 2017($0.32)$24.38 millionViewN/AView Earnings Details
5/11/2017Q1 2017($0.60)$27.98 millionViewN/AView Earnings Details
3/15/2017Q4 2016($1.21)$27.09 millionViewN/AView Earnings Details
11/9/2016Q3 2016($1.18)$26.71 millionViewN/AView Earnings Details
8/9/2016Q2 2016($0.60)$43.79 millionViewN/AView Earnings Details
5/5/2016Q1 2016($0.84)$44.76 millionViewN/AView Earnings Details
3/15/2016Q415($0.05)($0.03)$50.01 million$47.00 millionViewN/AView Earnings Details
8/4/2015Q2($0.02)($0.04)$51.90 million$46.60 millionViewListenView Earnings Details
4/30/2015Q1 2015($0.24)($0.36)$49.60 million$48.65 millionViewN/AView Earnings Details
2/26/2015Q414($0.01)($0.03)$54.81 million$53.60 millionViewListenView Earnings Details
10/30/2014Q3 2014$0.12($0.24)$52.40 million$51.01 millionViewN/AView Earnings Details
7/31/2014Q314($0.01)($0.02)$52.10 million$51.00 millionViewN/AView Earnings Details
4/30/2014Q1 2014($0.03)$0.01$50.65 million$49.17 millionViewN/AView Earnings Details
3/17/2014Q413($0.02)($0.02)$52.50 million$53.10 millionViewN/AView Earnings Details
11/7/2013Q3 2013($0.24)$0.12$47.85 million$50.20 millionViewN/AView Earnings Details
8/6/2013Q2 2013($0.24)($0.12)$49.50 million$51.02 millionViewN/AView Earnings Details
4/30/2013Q1 2013($0.36)($0.36)$50.51 million$50.44 millionViewN/AView Earnings Details
2/28/2013Q4 2012($0.12)($0.12)ViewN/AView Earnings Details
11/5/2012Q3 2012($0.12)$0.12ViewN/AView Earnings Details
8/7/2012Q2 2012($0.12)($0.12)ViewN/AView Earnings Details
5/8/2012Q1 2012($0.24)($0.17)ViewN/AView Earnings Details
2/28/2012Q4 2011($0.71)ViewN/AView Earnings Details
8/4/2011Q2 2011($0.24)ViewN/AView Earnings Details
5/4/2011Q1 2011$0.01ViewN/AView Earnings Details
2/24/2011Q4 2010($0.12)($0.20)ViewN/AView Earnings Details
11/8/2010Q3 2010($0.12)($0.10)ViewN/AView Earnings Details
8/5/2010Q2 2010$0.12($0.05)ViewN/AView Earnings Details
5/10/2010Q1 2010($0.12)($0.05)ViewN/AView Earnings Details
2/23/2010Q4 2009($0.12)$0.08ViewN/AView Earnings Details
11/9/2009Q3 2009($0.24)($0.24)ViewN/AView Earnings Details
8/3/2009Q2 2009($0.48)($1.61)ViewN/AView Earnings Details
5/4/2009Q1 2009($0.60)($0.79)ViewN/AView Earnings Details
3/2/2009Q4 2008($0.72)($1.31)ViewN/AView Earnings Details
11/3/2008Q3 2008($0.72)($1.25)ViewN/AView Earnings Details
8/4/2008Q2 2008($0.84)($0.94)ViewN/AView Earnings Details
4/24/2008Q1 2008($0.48)($0.88)ViewN/AView Earnings Details
2/13/2008Q4 2007($0.96)($0.65)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Alphatec (NASDAQ:ATEC) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.04 EPS
Next Year EPS Consensus Estimate: $-0.34 EPS

Dividends

Dividend History for Alphatec (NASDAQ:ATEC)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Alphatec (NASDAQ ATEC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 34.90%
Institutional Ownership Percentage: 15.69%
Insider Trades by Quarter for Alphatec (NASDAQ:ATEC)
Insider Trades by Quarter for Alphatec (NASDAQ:ATEC)

Alphatec (NASDAQ ATEC) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/25/2017Terry RichCEOBuy2,500$1.99$4,975.00207,958View SEC Filing  
8/17/2017Jeffrey G. BlackVPBuy5,000$1.80$9,000.00View SEC Filing  
8/16/2017Jeffrey G BlackVPBuy4,000$1.75$7,000.0079,000View SEC Filing  
8/15/2017Brian SniderEVPBuy3,000$1.69$5,070.0078,000View SEC Filing  
8/15/2017Terry RichCEOBuy2,958$1.69$4,999.02205,458View SEC Filing  
12/16/2016Leslie H CrossDirectorBuy15,000$4.25$63,750.0065,443View SEC Filing  
12/16/2016Terry RichCEOBuy2,500$4.26$10,650.00202,500View SEC Filing  
11/30/2016John FosterMajor ShareholderSell17,533$5.26$92,223.58View SEC Filing  
5/20/2015Mitsuo AsaiInsiderBuy10,000$1.39$13,900.00View SEC Filing  
12/10/2014Mitsuo AsaiInsiderBuy2,251$1.30$2,926.30View SEC Filing  
12/9/2014Mitsuo AsaiInsiderBuy7,749$1.30$10,073.70View SEC Filing  
5/14/2014James CorbettCEOBuy25,000$1.35$33,750.00275,000View SEC Filing  
5/14/2014Leslie CrossChairmanBuy10,000$1.35$13,500.00514,770View SEC Filing  
5/13/2014Leslie CrossChairmanBuy25,000$1.33$33,250.00504,770View SEC Filing  
11/30/2012Leslie H CrossCEOBuy20,000$1.60$32,000.00View SEC Filing  
11/29/2012Leslie H CrossCEOBuy10,819$1.55$16,769.45View SEC Filing  
11/26/2012Leslie H CrossCEOBuy20,000$1.56$31,200.00View SEC Filing  
11/21/2012Leslie H CrossCEOBuy10,000$1.55$15,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Alphatec (NASDAQ ATEC) News Headlines

Source:
DateHeadline
 Brokerages Anticipate Alphatec Holdings, Inc. (ATEC) to Announce -$0.21 EPS Brokerages Anticipate Alphatec Holdings, Inc. (ATEC) to Announce -$0.21 EPS
www.americanbankingnews.com - January 24 at 3:26 PM
Alphatec (ATEC) Raised to "Hold" at Zacks Investment ResearchAlphatec (ATEC) Raised to "Hold" at Zacks Investment Research
www.americanbankingnews.com - January 23 at 6:44 PM
BRIEF-Patrick Miles Reports 9.1 Pct Stake In Alphatec Holdings As Of Dec 28‍BRIEF-Patrick Miles Reports 9.1 Pct Stake In Alphatec Holdings As Of Dec 28‍
www.reuters.com - January 9 at 11:04 AM
Alphatec Holdings, Inc. (ATEC) Sees Significant Drop in Short InterestAlphatec Holdings, Inc. (ATEC) Sees Significant Drop in Short Interest
www.americanbankingnews.com - January 1 at 3:07 AM
 Alphatec Holdings, Inc. (ATEC) Given $4.33 Average Price Target by Analysts Alphatec Holdings, Inc. (ATEC) Given $4.33 Average Price Target by Analysts
www.americanbankingnews.com - December 26 at 4:07 PM
Alphatec Holdings, Inc. :ATEC-US: Earnings Analysis: Q3, 2017 By the Numbers : December 22, 2017Alphatec Holdings, Inc. :ATEC-US: Earnings Analysis: Q3, 2017 By the Numbers : December 22, 2017
finance.yahoo.com - December 22 at 11:27 AM
Alphatec (ATEC) Downgraded by ValuEngine to "Strong Sell"Alphatec (ATEC) Downgraded by ValuEngine to "Strong Sell"
www.americanbankingnews.com - December 3 at 10:50 PM
HC Wainwright Reaffirms "Buy" Rating for Alphatec Holdings, Inc. (ATEC)HC Wainwright Reaffirms "Buy" Rating for Alphatec Holdings, Inc. (ATEC)
www.americanbankingnews.com - November 22 at 4:26 PM
 Analysts Set $4.33 Price Target for Alphatec Holdings, Inc. (ATEC) Analysts Set $4.33 Price Target for Alphatec Holdings, Inc. (ATEC)
www.americanbankingnews.com - November 18 at 3:37 AM
Alphatec Holdings (ATEC) CEO Terry Rich on Q3 2017 Results - Earnings Call TranscriptAlphatec Holdings' (ATEC) CEO Terry Rich on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 11 at 9:47 AM
Alphatec Holdings, Inc. to Host Earnings CallAlphatec Holdings, Inc. to Host Earnings Call
finance.yahoo.com - November 10 at 1:40 PM
Edited Transcript of ATEC earnings conference call or presentation 9-Nov-17 9:30pm GMTEdited Transcript of ATEC earnings conference call or presentation 9-Nov-17 9:30pm GMT
finance.yahoo.com - November 10 at 1:40 PM
Investor Network: Alphatec Holdings, Inc. to Host Earnings CallInvestor Network: Alphatec Holdings, Inc. to Host Earnings Call
www.finanznachrichten.de - November 9 at 5:20 PM
Alphatec Holdings, Inc. Reports Third Quarter 2017 Financial ResultsAlphatec Holdings, Inc. Reports Third Quarter 2017 Financial Results
www.thestreet.com - November 9 at 5:20 PM
BRIEF-Alphatec Holdings Inc posts Q3 loss per share ‍$0.23BRIEF-Alphatec Holdings Inc posts Q3 loss per share ‍$0.23
www.reuters.com - November 9 at 5:20 PM
Spine Biologics Market Expected To Be Worth US$ 2.5 Billion Globally By 2022Spine Biologics Market Expected To Be Worth US$ 2.5 Billion Globally By 2022
www.marketwatch.com - November 7 at 10:58 PM
Global Lumbar Spine Fusion Sales Market will Rise at a CAGR of 4.9% by 2022Global Lumbar Spine Fusion Sales Market will Rise at a CAGR of 4.9% by 2022
www.marketwatch.com - October 30 at 10:12 PM
Alphatec Holdings, Inc. (ATEC) Sees Large Increase in Short InterestAlphatec Holdings, Inc. (ATEC) Sees Large Increase in Short Interest
www.americanbankingnews.com - October 28 at 1:26 AM
Alphatec Announces Preliminary Third Quarter 2017 Financial Results And Corporate UpdatesAlphatec Announces Preliminary Third Quarter 2017 Financial Results And Corporate Updates
globenewswire.com - October 25 at 3:59 AM
BRIEF-Alphatec Holdings files for mixed shelf of up to $100 mlnBRIEF-Alphatec Holdings files for mixed shelf of up to $100 mln
www.reuters.com - October 25 at 3:58 AM
Alphatec Announces Preliminary Third Quarter 2017 Financial Results And Corporate UpdatesAlphatec Announces Preliminary Third Quarter 2017 Financial Results And Corporate Updates
finance.yahoo.com - October 24 at 5:57 PM
Alphatec Denounces “Baseless” NuVasive ComplaintAlphatec Denounces “Baseless” NuVasive Complaint
finance.yahoo.com - October 11 at 5:38 PM
NuVasive (NUVA) Files Lawsuit Against Former Vice ChairmanNuVasive (NUVA) Files Lawsuit Against Former Vice Chairman
www.streetinsider.com - October 11 at 3:28 AM
NuVasive sues former executive who moved to rival AlphatecNuVasive sues former executive who moved to rival Alphatec
finance.yahoo.com - October 10 at 10:27 PM
Nuvasive Files Lawsuit Against Patrick S. Miles To Protect Corporate Assets And Stakeholders InterestsNuvasive Files Lawsuit Against Patrick S. Miles To Protect Corporate Assets And Stakeholders' Interests
finance.yahoo.com - October 10 at 5:26 PM
Head-To-Head Comparison: Alphatec Holdings (ATEC) vs. Sequenom (SQNM)Head-To-Head Comparison: Alphatec Holdings (ATEC) vs. Sequenom (SQNM)
www.americanbankingnews.com - October 6 at 12:12 PM
Varex Imaging (VREX) and Alphatec Holdings (ATEC) Head to Head ReviewVarex Imaging (VREX) and Alphatec Holdings (ATEC) Head to Head Review
www.americanbankingnews.com - October 4 at 12:28 PM
Should You Worry About Alphatec Holdings Inc (ATEC) Cash Runway?Should You Worry About Alphatec Holdings Inc (ATEC) Cash Runway?
finance.yahoo.com - October 3 at 3:52 PM
Varex Imaging (VREX) & Alphatec Holdings (ATEC) Critical ComparisonVarex Imaging (VREX) & Alphatec Holdings (ATEC) Critical Comparison
www.americanbankingnews.com - October 2 at 8:36 PM
Mid-Day Market Update: Crude Oil Down Over 2%; Endocyte Shares Spike HigherMid-Day Market Update: Crude Oil Down Over 2%; Endocyte Shares Spike Higher
www.nasdaq.com - October 2 at 4:01 PM
BRIEF-Alphatec announces additional spine-experienced leadership appointmentsBRIEF-Alphatec announces additional spine-experienced leadership appointments
www.reuters.com - October 2 at 4:01 PM
Alphatec Accelerates Business Transformation with Additional Spine-Experienced Leadership AppointmentsAlphatec Accelerates Business Transformation with Additional Spine-Experienced Leadership Appointments
globenewswire.com - October 2 at 4:01 PM
Critical Survey: Varex Imaging (VREX) & Alphatec Holdings (ATEC)Critical Survey: Varex Imaging (VREX) & Alphatec Holdings (ATEC)
www.americanbankingnews.com - September 24 at 10:20 AM
Head-To-Head Survey: Sequenom (SQNM) vs. Alphatec Holdings (ATEC)Head-To-Head Survey: Sequenom (SQNM) vs. Alphatec Holdings (ATEC)
www.americanbankingnews.com - September 20 at 2:22 PM
Financial Review: Sequenom (SQNM) and Alphatec Holdings (ATEC)Financial Review: Sequenom (SQNM) and Alphatec Holdings (ATEC)
www.americanbankingnews.com - September 16 at 6:14 AM
Should You Buy Alphatec Holdings Inc (ATEC)?Should You Buy Alphatec Holdings Inc (ATEC)?
finance.yahoo.com - September 15 at 9:31 PM
Alphatec Holdings (ATEC) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - SlideshowAlphatec Holdings (ATEC) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - Slideshow
seekingalpha.com - September 12 at 4:22 PM
Alphatec Holdings, Inc. :ATEC-US: Earnings Analysis: Q2, 2017 By the Numbers : September 7, 2017Alphatec Holdings, Inc. :ATEC-US: Earnings Analysis: Q2, 2017 By the Numbers : September 7, 2017
finance.yahoo.com - September 7 at 4:09 PM
Alphatec Holdings, Inc. Announces Participation at the 19th Annual Rodman & Renshaw Global Investment ConferenceAlphatec Holdings, Inc. Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference
finance.yahoo.com - August 30 at 5:20 PM
Global Spinal Fusion Market 2017-2022: Unfavorable Reimbursement Policies and Stringent Regulatory Framework May Restrain Market Growth - Research and MarketsGlobal Spinal Fusion Market 2017-2022: Unfavorable Reimbursement Policies and Stringent Regulatory Framework May Restrain Market Growth - Research and Markets
www.businesswire.com - August 25 at 5:46 PM
Edited Transcript of ATEC earnings conference call or presentation 10-Aug-17 8:30pm GMTEdited Transcript of ATEC earnings conference call or presentation 10-Aug-17 8:30pm GMT
finance.yahoo.com - August 11 at 9:43 PM
Alphatec Holdings, Inc. (NASDAQ:ATEC) Releases  Earnings ResultsAlphatec Holdings, Inc. (NASDAQ:ATEC) Releases Earnings Results
www.americanbankingnews.com - August 11 at 3:40 PM
Alphatec Holdings (ATEC) CEO Terry Rich on Q2 2017 Results - Earnings Call TranscriptAlphatec Holdings' (ATEC) CEO Terry Rich on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - August 11 at 1:48 AM
Alphatec Holdings, Inc. Reports Second Quarter 2017 Financial ResultsAlphatec Holdings, Inc. Reports Second Quarter 2017 Financial Results
finance.yahoo.com - August 10 at 8:46 PM
Alphatec reports 2Q lossAlphatec reports 2Q loss
finance.yahoo.com - August 10 at 8:46 PM
Comparing Alphatec Holdings (NASDAQ:ATEC) & Vascular Solutions (VASC)Comparing Alphatec Holdings (NASDAQ:ATEC) & Vascular Solutions (VASC)
www.americanbankingnews.com - August 9 at 2:12 PM
Critical Comparison: Vascular Solutions (VASC) vs. Alphatec Holdings (NASDAQ:ATEC)Critical Comparison: Vascular Solutions (VASC) vs. Alphatec Holdings (NASDAQ:ATEC)
www.americanbankingnews.com - August 8 at 7:46 AM
Montco medical device developer buys Swiss robotics companyMontco medical device developer buys Swiss robotics company
www.bizjournals.com - August 3 at 10:37 PM
Alphatec Holdings to Report Second Quarter 2017 Financial Results on August 10, 2017Alphatec Holdings to Report Second Quarter 2017 Financial Results on August 10, 2017
finance.yahoo.com - August 1 at 10:04 PM
Head to Head Review: Alphatec Holdings (NASDAQ:ATEC) versus Vascular Solutions (VASC)Head to Head Review: Alphatec Holdings (NASDAQ:ATEC) versus Vascular Solutions (VASC)
www.americanbankingnews.com - July 27 at 9:36 AM

SEC Filings

Alphatec (NASDAQ:ATEC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Alphatec (NASDAQ:ATEC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Alphatec (NASDAQ ATEC) Stock Chart for Saturday, February, 17, 2018

Loading chart…

This page was last updated on 2/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.